292 related articles for article (PubMed ID: 30253780)
1. Genetically enhancing the expression of chemokine domain of CX
Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K
J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780
[TBL] [Abstract][Full Text] [Related]
2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.
Nash KR; Lee DC; Hunt JB; Morganti JM; Selenica ML; Moran P; Reid P; Brownlow M; Guang-Yu Yang C; Savalia M; Gemma C; Bickford PC; Gordon MN; Morgan D
Neurobiol Aging; 2013 Jun; 34(6):1540-8. PubMed ID: 23332170
[TBL] [Abstract][Full Text] [Related]
4. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tau pathology by the microglial fractalkine receptor.
Bhaskar K; Konerth M; Kokiko-Cochran ON; Cardona A; Ransohoff RM; Lamb BT
Neuron; 2010 Oct; 68(1):19-31. PubMed ID: 20920788
[TBL] [Abstract][Full Text] [Related]
6. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
8. CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies.
Castro-Sánchez S; García-Yagüe ÁJ; Kügler S; Lastres-Becker I
Redox Biol; 2019 Apr; 22():101118. PubMed ID: 30769286
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
[TBL] [Abstract][Full Text] [Related]
10. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
[TBL] [Abstract][Full Text] [Related]
11. Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction.
Fan Q; He W; Gayen M; Benoit MR; Luo X; Hu X; Yan R
J Neurosci; 2020 Jan; 40(5):1133-1144. PubMed ID: 31822518
[TBL] [Abstract][Full Text] [Related]
12. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.
Rogers JT; Morganti JM; Bachstetter AD; Hudson CE; Peters MM; Grimmig BA; Weeber EJ; Bickford PC; Gemma C
J Neurosci; 2011 Nov; 31(45):16241-50. PubMed ID: 22072675
[TBL] [Abstract][Full Text] [Related]
13. Absence of microglia or presence of peripherally-derived macrophages does not affect tau pathology in young or old hTau mice.
Zhu K; Pieber M; Han J; Blomgren K; Zhang XM; Harris RA; Lund H
Glia; 2020 Jul; 68(7):1466-1478. PubMed ID: 32039516
[TBL] [Abstract][Full Text] [Related]
14. Absence of CX3CR1 impairs the internalization of Tau by microglia.
Bolós M; Llorens-Martín M; Perea JR; Jurado-Arjona J; Rábano A; Hernández F; Avila J
Mol Neurodegener; 2017 Aug; 12(1):59. PubMed ID: 28810892
[TBL] [Abstract][Full Text] [Related]
15. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model.
Finneran DJ; Morgan D; Gordon MN; Nash KR
J Neuroimmune Pharmacol; 2019 Jun; 14(2):312-325. PubMed ID: 30499006
[TBL] [Abstract][Full Text] [Related]
16. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and Aβ1-42 gene transfer models.
Hebron ML; Algarzae NK; Lonskaya I; Moussa C
Exp Neurol; 2014 Jan; 251():127-38. PubMed ID: 23333589
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.
Weston LL; Jiang S; Chisholm D; Jantzie LL; Bhaskar K
J Neuroinflammation; 2021 Jul; 18(1):161. PubMed ID: 34275478
[TBL] [Abstract][Full Text] [Related]
19. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
Front Immunol; 2020; 11():997. PubMed ID: 32508844
[TBL] [Abstract][Full Text] [Related]
20. Microglia lacking a peroxisomal β-oxidation enzyme chronically alter their inflammatory profile without evoking neuronal and behavioral deficits.
Beckers L; Geric I; Stroobants S; Beel S; Van Damme P; D'Hooge R; Baes M
J Neuroinflammation; 2019 Mar; 16(1):61. PubMed ID: 30866963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
